Literature DB >> 26750124

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding-Part I: standard and biologic disease modifying anti-rheumatic drugs and corticosteroids.

Julia Flint1, Sonia Panchal2, Alice Hurrell3, Maud van de Venne4, Mary Gayed5, Karen Schreiber6, Subha Arthanari7, Joel Cunningham3, Lucy Flanders3, Louise Moore8, Amy Crossley9, Neetha Purushotham3, Amisha Desai5, Madeleine Piper10, Mohamed Nisar7, Munther Khamashta11, David Williams3, Caroline Gordon12, Ian Giles13.   

Abstract

Keywords:  DMARDs; biologics; breastfeeding; corticosteroids; hydroxychloroquine; pregnancy; prescribing; rheumatic disease

Mesh：

Substances：

Year:  2016        PMID： 26750124     DOI： 10.1093/rheumatology/kev404

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  76 in total

Review 1.  A comprehensive review of rituximab therapy in rheumatoid arthritis patients.

Authors:  Soheil Tavakolpour; Samira Alesaeidi; Mohammad Darvishi; Mojtaba GhasemiAdl; Sahar Darabi-Monadi; Meisam Akhlaghdoust; Somayeh Elikaei Behjati; Arash Jafarieh
Journal:  Clin Rheumatol       Date:  2019-08-01       Impact factor: 2.980

2.  Antisynthetase syndrome in pregnancy: A case and review of the literature.

Authors:  Lauren J Green; Lorraine O'Neill; Charlotte J Frise
Journal:  Obstet Med       Date:  2018-11-08

3.  Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.

Authors:  J A Walsh; A B Gottlieb; B Hoepken; T Nurminen; P J Mease
Journal:  Clin Rheumatol       Date:  2018-09-06       Impact factor: 2.980

Review 4.  The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy.

Authors:  Bonnie L Bermas; Melissa Tassinari; Megan Clowse; Eliza Chakravarty
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580

5.  Therapy: A fine conception -- BSR/BHPR guidelines on drugs in pregnancy.

Authors:  Lisa R Sammaritano; Bonnie L Bermas
Journal:  Nat Rev Rheumatol       Date:  2016-03-17       Impact factor: 20.543

Review 6.  Tocilizumab (Actemra).

Authors:  Martin Sheppard; Faidra Laskou; Philip P Stapleton; Shahryar Hadavi; Bhaskar Dasgupta
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

Review 7.  Medical problems in pregnancy.

Authors:  Bhaskar Narayan; Catherine Nelson-Piercy
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

Review 8.  Family Planning and Rheumatoid Arthritis.

Authors:  Nicole Hunt; Mehret Birru Talabi
Journal:  Curr Rheumatol Rep       Date:  2019-03-06       Impact factor: 4.592

Review 9.  Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage.

Authors:  Claire de Moreuil; Zarrin Alavi; Elisabeth Pasquier
Journal:  Br J Clin Pharmacol       Date:  2019-12-17       Impact factor: 4.335

Review 10.  The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy.

Authors:  May Ching Soh; Marcelo Moretto
Journal:  Obstet Med       Date:  2019-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.